Inhibition of Insulin-Degrading Enzyme Does Not Increase Islet Amyloid Deposition in Vitro

about

Inhibition of Insulin-Degrading Enzyme Does Not Increase Islet Amyloid Deposition in Vitro

Item

http://www.wikidata.org/entity/Q38758608

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Inhibition of Insulin-Degradin ...... et Amyloid Deposition in Vitro

@en

type

Item

label

Inhibition of Insulin-Degradin ...... et Amyloid Deposition in Vitro

@en

prefLabel

Inhibition of Insulin-Degradin ...... et Amyloid Deposition in Vitro

@en

P1476

Inhibition of Insulin-Degradin ...... et Amyloid Deposition in Vitro

@en

P2093

Andrew T Templin

http://www.w3.org/2001/XMLSchema#string

Daniel T Meier

http://www.w3.org/2001/XMLSchema#string

Mahnaz Mellati

http://www.w3.org/2001/XMLSchema#string

Malcolm A Leissring

http://www.w3.org/2001/XMLSchema#string

Meghan F Hogan

http://www.w3.org/2001/XMLSchema#string

Rebecca L Hull

http://www.w3.org/2001/XMLSchema#string

Sakeneh Zraika

http://www.w3.org/2001/XMLSchema#string

P2860

Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin

Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones

Insulin degradation: progress and potential

Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation

Neprilysin impedes islet amyloid formation by inhibition of fibril formation rather than peptide degradation.

Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology.

β-cell loss and β-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition.

The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.

Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets.

Glucose- and time-dependence of islet amyloid formation in vitro.

P304

3462-3468

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/EN.2016-1410

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

157

http://www.w3.org/2001/XMLSchema#string

P50

Steven E. Kahn

P577

2016-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27404391

http://www.w3.org/2001/XMLSchema#string

P932

5007890

http://www.w3.org/2001/XMLSchema#string